AHA: Statins in the Water? HS-CRP as a Therapeutic Target?





The interactive transcript could not be loaded.



Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Nov 17, 2008


NEW ORLEANS, Nov. 9 -- Results of the JUPITER trial are likely to expand use of statins and highly-sensitive CRP measurement, but how much and how soon remain to be seen, according to participants in an exclusive MedPage Today roundtable discussion.
Robert Bonow, M.D., of Northwestern University in Chicago and a former president of the American Heart Association, Gordon F. Tomaselli, M.D., of Johns Hopkins University in Baltimore and chairman of the association's program committee, and Anthony De Maria, M.D., of the University of California at San Diego and editor-in-chief of the Journal of the American College of Cardiology, sat down with Peggy Peck, MedPage Today executive editor, to look at the clinical implications of the landmark trial.

One thing all three agreed on: The results are likely to bring about changes in clinical guidelines.

Medpage Today: http://medpagetoday.com
Online CME - Continuing medical education: http://www.medpagetoday.com/cme/
Latest medical news: http://www.medpagetoday.com/latest/

The MedPage Today app:
iOS: https://goo.gl/JKrkHq
Android: https://play.google.com/store/apps/de...

MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageT...
Medpage Today on Facebook: https://www.facebook.com/MedPageToday

  • Category

  • License

    • Standard YouTube License


to add this to Watch Later

Add to

Loading playlists...